The licence beat supports our continued buy.
Our findings support the continued development of a national control strategy that extends influenza vaccination to young children and improves access to antiviral medications.
Our results support the continued development of CYD-TDV for the prevention of dengue disease, and herald the promise of a commercially available vaccine in the coming years.
Although therefore differing in design from more commonly-used prospective studies, precluding direct comparison of results, our findings do support the continued development of vaccines based on specific P. falciparum asexual stage antigens.
Nevertheless, our data do support the continued development of additional STR options, to broaden the number of patients for whom this is an option and the number of subsequent beneficial outcomes.
Their award will be used to support the continued development of a prototype and associated electronics with the goal of commercializing the system over the next year.
These results support the continued development of an axial-flow, mechanical cavopulmonary assist device as a new clinical therapeutic option for Fontan patients.
Our findings emphasise the importance of taking geographic differences into account when designing global vaccine interventions and support the continued development of SP0148, SP1912 and SP2108 as protein vaccine candidates against this important pneumococcal serotype.
Pharmacokinetic evaluation of compound 28 in mice revealed good brain penetration, as well as good clearance, half-life, and volume of distribution which collectively support the continued development of this class of compounds.
The DM cats were significantly older and heavier than the control cats, which may have contributed to differences in parameters of oxidative stress and levels of antioxidant enzymes between these groups, but the decreased level of SOD enzyme in the diabetic group would appear to support the continued development of targeted antioxidant supplementation for this cats with this disease.
BACKGROUND: Previous clinical efficacy trials failed to support the continued development of recombinant gp120 (rgp120) as a candidate HIV vaccine.
